
SafePAS OÜ, operating under the brand Drug Hunter, develops and markets the Drug Hunter Analyzer, a portable, on-the-spot drug testing device that provides immediate quantitative results for illegal drugs in oral fluid (saliva). The technology integrates capillary electrophoresis and deep UV fluorescence detection with a machine learning-based expert system to accurately identify and quantify multiple illegal drugs, even in multidrug abuse cases. The product is designed for use by police, customs, prisons, hospitals, forensic labs, and workplaces, addressing limitations of traditional immunoassay tests by offering precise, reliable, and fast results. The company has strong institutional backing from the Estonian Ministry of the Interior and EU funding, with a vision to enhance safety by enabling trusted drug testing in various safety-critical environments.

SafePAS OÜ, operating under the brand Drug Hunter, develops and markets the Drug Hunter Analyzer, a portable, on-the-spot drug testing device that provides immediate quantitative results for illegal drugs in oral fluid (saliva). The technology integrates capillary electrophoresis and deep UV fluorescence detection with a machine learning-based expert system to accurately identify and quantify multiple illegal drugs, even in multidrug abuse cases. The product is designed for use by police, customs, prisons, hospitals, forensic labs, and workplaces, addressing limitations of traditional immunoassay tests by offering precise, reliable, and fast results. The company has strong institutional backing from the Estonian Ministry of the Interior and EU funding, with a vision to enhance safety by enabling trusted drug testing in various safety-critical environments.